glp-1 que es Agonistas del receptor de péptido similar al glucagón tipo 1 (GLP-1) en el manejo del paciente con diabetes mellitus tipo 2. Una aproximación para el nefrólogo Understanding GLP-1 medications

Microdosing Approach: Suitable for individuals with high sensitivity to medications

Mol Metab (2014) 4(1):314

In 2021, China had 141 million people with diabetes, projected to rise to 164 million by 2030 the highest globally, according to the International Diabetes Federation

and support to attend national diabetes meetings from Eli Lilly

Priyali Singh, MD Jul 2, 2026 10 min read Best-in-class care is a click away Find everything and everyone you need to reach your metabolic health goals, in one place

GLP-1/glucagon co-agonists such as cotadutide and efinopegdutide offer the promise of increased efficacy whilst minimising side effects